SPRO: Spero Therapeutics, Inc. Stock

by  •  • Comments Off on SPRO: Spero Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 53.11
Enterprise Value ($M) -23.18
Book Value ($M) 65.51
Book Value / Share 1.20
Price / Book 0.81
NCAV ($M) 61.97
NCAV / Share 1.14
Price / NCAV 0.86

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.03

Liquidity (mrq)
Quick Ratio 2.68
Current Ratio 2.68

Balance Sheet (mrq) ($M)
Current Assets 131.63
Assets 135.16
Liabilities 69.65
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Anson Funds Management LP 6.90 -12.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 70,818 579,554 12.22
2025-01-14 36,180 158,835 22.78
2025-01-13 26,300 154,949 16.97
2025-01-10 51,356 194,409 26.42

(click for more detail)

Similar Companies
SLDB – Solid Biosciences Inc. SLRN – Acelyrin, Inc.
SNDX – Syndax Pharmaceuticals, Inc. SRPT – Sarepta Therapeutics, Inc.
SRRK – Scholar Rock Holding Corporation


Financial data and stock pages provided by
Fintel.io